Introduction
Chronic kidney disease (CKD) is becoming a serious problem of public health (1) . The term refers to a disease syndrome which involves a decrease in the number of active nephrons, which results from various pathological processes, occurring in renal interstitium (2) . Glomerular filtration rate which has been lower than 60 mL/min/1.73 m 2 for at least 3 months and results of laboratory tests, confirming renal damage, e.g. albuminuria, are grounds for diagnosing the above disease. In clinical practice, the function of the organ is evaluated on the basis of the estimated glomerular filtration rate (eGFR) (3) . It is supposed that 3.2 million patients worldwide are treated due to chronic renal failure. Of that number, 2.25 million are haemodialysed. 272.000 patients are treated with peritoneal dialysis and 678.000 have undergone kidney transplantation (4) .
In developed countries, most common causes of CKD include: diabetes, arterial hypertension, glomerulonephritis and autosomal dominant polycystic kidney disease (5) . In developing countries, infectious aetiology is dominant (1) . In its initial stage, the disease is latent. This latency favours development of multiorgan changes, which mostly results from arterial hypertension, anaemia, dyslipidemia as well as disturbed acid-base, mineral and water-electrolyte balance.
Renal replacement therapy, particularly haemodialysis, substantially affects the quality of patient's life. Thus, the decision on initiating such a therapy is taken for each individual patient. A doctor takes the patient's biochemical parameters into account. However, intensity and severity of disease symptoms are key factors before taking the decision. Abstaining from implementing this therapy could be explained by the fact that haemodialysotherapy may contribute to negative processes, such as dysfunction of endothelial cells of blood vessels or even accelerated atherosclerosis. It is believed that oxidative stress, arising from prolonged catheterization of blood vessels and insufficient biocompatibility of membranes in the filter of the dialysis device, causes those disturbances (6) .
Bearing in mind that CKD-related processes and also haemodialysotherapy might affect the function of the visual system (7, 8) , due to e.g. decreased visual acuity, the authors decided to conduct relevant studies.
Aim
The aim of the study was to evaluate changes in functional parameters of the visual system in patients with severe and end-stage kidney disease.
Material and Methods
Chronic kidney disease, documented at least 6 months prior to the ophthalmological examination, was an inclusion criterion.
A particularly important exclusion criterion was diabetes, confirmed with the patient's medical records or diagnosed on the basis of diagnostic criteria, set by the World Health Organization (WHO) (9) . Besides, unregulated arterial hypertension and extraocular or intraocular opthalmological procedures, performed at least 6 months prior the study, were other exclusion criteria.
Before implementing the project, the Bioethics Committee of the Medical University of Lodz had given a positive opinion. The research was conducted according to the Declaration of Helsinki. All patients signed a written consent for their participation in the study. Seventy two people (144 eyes) were included in the study.
Depending on the value of estimated glomerular filtration rate (eGFR) and the applied therapy, the studied people were divided into three groups of the same size. Group I consisted of patients with chronic renal failure, treated with haemodialysis (CKD, stage 5); patients with severe CKD stage, with markedly decreased glomerular filtration (CKD, stage 4,) were included in Group II and people with normal glomerular filtration were included in Group III (Tab. I).
In Group I, causes of chronic kidney disease included: unknown factor (6 patients, 25.02%), chronic glomerulonephritis (5 patients, 20.85%), nephrolithiasis (4 patients, 16.68%), polycystic renal degeneration (3 patients, 12.51%), hypertensive nephropathy (3 patients, 12.51%), toxic drug reaction (1 patient, 4.17%), chronic interstitial nephritis (1 patient, 4.17%) and Wegener's granulomatosis (1 patient, 4.17%).
In Group II, causes of chronic kidney disease included: polycystic renal degeneration (7 patients, 29.19%), chronic glomerulonephritis (6 patients, 25.02%), unknown factor (4 patients, 16.68%), nephrolithiasis (2 patients, 8.34%), hypertensive nephropathy (1 patient, 4.17%), toxic drug reaction (1 patient, 4.17%), unilateral renal hypoplasia and contralateral nephrectomy (1 patient, 4.17%), after trauma (1 patient, 4.17%) and Ormond's syndrome (1 patient, 4.17%).
Respondents from Group III, not affected by the above disease, made regular medical appointments due to: nephrolithiasis (15 people, 62.55%), recurrent urinary tract infections (6 people, 25.02%) and single renal cysts (3 people, 12.51%).
The analysis of best-corrected visual acuity (BCVA) was preceded by spherocylindrical correction for distance and near 
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AgnieszkA gAjdowskA, Piotr jurowski vision, and conducted with the application of an examination technique, prepared by Regan and Boeder and modified by Habela (10) . The analysis was carried out using Snellen optotypes for distance and near visual acuity assessment. The value was 0.001 if, during the best-corrected distance visual acuity assessment, the patient reported only light perception. If the patient could see hand movements in front of his/her eye, the recorded value was 0.005. If he/she was able to count fingers from a distance of 1 meter, the value was 0.01. In the event of lack of light perception, the score was 0. For a patient who was not able to make out the biggest optotypes for near vision but his/ her distance visual acuity was at least equal to light perception, the result of the best-corrected near visual acuity assessment was identified as 3.5/30 cm. Due to poor health of many participants of the study, the authors used the Pelli-Robson contrast sensitivity chart in order to assess the patients' contrast sensitivity and Farnsworth 15 Hue test to evaluate colour vision. The authors used these tests since they were easy to apply and reliable. Besides, they allowed for conducting a further statistical analysis. Each eye was tested separately with the application of the best correction. In the Pelli-Robson test the authors recorded the last triplet, of which at least two elements were identified correctly. Then, they recorded the value which corresponded to the triplet on the chart. As for colour vision, it was identified as:
• normal -all hue tiles were arranged in a correct sequence, • mildly disturbed -hue tiles were incorrectly arranged in not more than three positions,
• single-axis disturbances -the course of the sequence corresponded to the main confusion axis of colour vision: red (protan), green (deutan) or blue (tritan), • severely disturbed -the line connecting tiles numbers did not correspond to any of the above sequences; a lot of tiles were incorrectly arranged, which implied multi-axis disturbances. Slit lamp examination was performed to evaluate crystalline lens and macula. Blood sample was obtained from every person in order to measure serum carboxymethyllysine (CML) concentration with ELISA test (EIAab, Wuhan, China). CML belongs to large group of advanced glycation-end products (AGE) which are observed to accumulate in CKD patients (11) .
The authors used the Kruskal-Wallis test and chi-square test. The Dunn's test was used in order to analyse relationships among the studied groups. Tab. II. Best-corrected distance and near visual acuity results in study groups. Tab. II. Wyniki badania najlepszej skorygowanej ostrości wzroku do dali i bliży w badanych grupach.
Disturbances of functional parameters of the visual system in conservatively treated and haemodialysed patients with non-diabetic chronic kidney disease
No light perception as well as hand movements in front of patient's eye were not observed in studied groups. The lowest recorded value of distance visual acuity was 0.001 in Group I for a patient with advanced cataract. Counting fingers from a distance of 1 meter recorded as 0.01 was present in one patient from Group I with history of uveitis and in one patient from Group II due to previous corneal graft. Poor near visual outcome identified as 3.5/30 cm was present in afore mentioned patients and also in case of bilateral central retinal vein occlusion (Group I) and in strabismus amblyopia (Group II).
The analysis confirmed a statistically significant difference (p = 0.004895) in contrast sensitivity in Group II and Group III. The authors did not observe any statistically significant differences between groups: I and II (p = 0.412490) or groups: I and III (p = 0.287730) (tab. III).
An analysis of colour vision confirmed a statistically significant difference between study groups (p = 0.027). Group I most often demonstrated mild disturbances (16 eyes, 33.33%) and single-axis disturbances (14 eyes, 29.17%). Severe, multi--axis disturbances were noted in this group in 5 eyes (10.42%). Patients from Group II were usually affected by mild colour vision disturbances (14 eyes, 29.17%); less frequently did they have severe colour vision anomalies (12 eyes, 25%). Single-axis anomalies were noted in 9 eyes (18.75%). Farnsworth 15 Hue test, performed in Group III, revealed mild colour vision disturbances in as many as 25 eyes (52.08%); single-axis anomalies were observed in 7 eyes (14.58%) and severe disturbances were noted in 4 eyes (8.33%) (tab. IV).
Crystalline lens transparency was significantly different between groups (p = 0.0031). Cortical or nuclear cataract was observed more frequently in group I (19 eyes, 39.58%), less frequently in group II, (7 eyes, 14.58%) whereas the rarest it was in group III (5 eyes, 10.42%). Percent of initial opacification of the lens was in groups I,II and III as follows: 47.92% 
AgnieszkA gAjdowskA, Piotr jurowski (23 eyes), 58.33% (28 eyes) and 66.67% (32 eyes), respectively. Cataract surgery was performed mainly in patients in group II (11 eyes, 22.92%) and group III (9 eyes, 18.75%), rarely in group I (2 eyes, 4.17%) (Tab. V). Analysis of macular changes showed significant differences only in occurrence of dry age-related macular degeneration (AMD) between examined groups (p = 0.008). The most often it was observed in group III (18 eyes, 37.50%), rarely in group II (10 eyes, 20.83%), uncommonly in group I (4 eyes, 9.30%). Because of very rare appearance of wet AMD, epiretinal membranes, and other changes in macula, they were not included in statistical analysis.
Analysis of CML concentration revealed significant differences between groups I and III (p = 0.001450) and also II and III (p = 0.001325), with mean values as follows: 9.76 ± 3.43 ng/mL, median 8.31 ng/mL (group I), 11.11 ± 5.49 ng/mL, median 9.24 ng/mL (group II) and 6.65 ± 2.06 ng/mL, median 6.43 ng/mL (group III) (Tab. VI).
Discussion
Despite relatively low mean distance visual acuity in the haemodialysed patients, only two of them (8.33%) met criteria for severely decreased visual acuity, according to standards set forth by WHO -H 54.1 in ICD-10 (12). In contrast to the above results, we can mention a study conducted by Chiu et al., who observed that 39% of patients met criteria for classifying them as legally blind (7). The age of the studied patients (64.42 ± 12.81 years vs. 74.9 ± 6.1 years) as well as the size of the groups (24 patients vs. 159 patients) might have contributed to such huge differences. Differences regarding the aetiology of CKD are striking. The authors of this study excluded diabetic patients, whereas in the study carried out by Chiu et al., patients with diabetes made up almost half the studied population. Bearing in mind the above observations, it should be pointed out that diabetics demonstrate microangiopathy not only in kidneys but also in the visual system, which can be mildly or severely affected by the disease (13 
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Disturbances of functional parameters of the visual system in conservatively treated and haemodialysed patients with non-diabetic chronic kidney disease exemplifies this observation. The author noted that 45.5 -50% patients with proliferative diabetic retinopathy are also affected by concomitant diabetic nephropathy (14) . Other researchers, Yoshimoto and Matsumoto, observed that as many as 21% of patients who started to be treated with haemodialysis, demonstrated decreased visual acuity (15) . The above study results as well as the authors' own observations and clinical experience confirm a considerable impact of diabetes on the function of the visual system, including visual acuity in CKD patients. In our study, proper criteria, excluding diabetics from the study, allowed us to create a homogenous, well selected group of patients. It should also be emphasized that currently in professional literature there are no reports on evaluation of changes in visual parameters in conservatively treated and chronically haemodialysed non-diabetic CKD patients. An analysis of prevalence of cataract, conducted in the study groups, might help to identify the source of potential causes of functional changes. It was observed in 19 eyes in patients from Group I, in 7 eyes in Group II, and in 5 eyes in Group III. The authors revealed that higher cataract prevalence corresponded to lowered mean visual acuity. 22 eyes in total udergone cataract extraction but unfortunately no data on implanted intraocular lens type were available.
The authors noted that patients with advanced CKD (Group II) demonstrated, in comparison to the other groups, the lowest mean contrast sensitivity. Its value was statistically different from the group with normal renal function. Professional literature does not contain comparative analyses on contrast sensitivity and colour vision in patients with CKD, stages 4 and 5. Woo et al. noted an improvement in contrast sensitivity after one dialysis session in patients with end stage of CKD (8). Chiu et al. evaluated functional changes in the visual system in old-age haemodialysed patients and made an interesting observation (7) . Results of the study imply that a high percentage of patients is affected with lowered contrast sensitivity (37%).
The authors of this study did not confirm a statistical difference with regards to contrast sensitivity in patients with advanced and end stage of CKD (Group I and Group II). However, its mean value was slightly higher in haemodialysed patients. Moreover, patients with advanced stage of CKD (Group II) demonstrated severe multi-axis colour vision disturbances and the prevalence was statistically significant. What is interesting, such disturbances occurred 2.5 times less frequently in haemodialysed patients. With regards to subjects from Group III, visual disturbances were observed less often and they were less severe. Thus, it can be concluded that CKD has a negative impact on the function of the visual system. Results obtained by Woo et al. (8) imply that dialysis therapy has a positive effect on contrast sensitivity and colour vision, which might result from the fact that during a dialysis session, uraemic toxins are partly but regularly removed from the body.
The influence of CKD on the visual system is related to dysfunction of neural cells. Some researchers point out a negative impact of electrolyte disturbances on neural activity and mention hyperkalaemia (16, 17) and hypermagnesaemia (18) , but it should be underlined that none of these concerned visual pathway neurons. However, some study teams question this relationship (19) . While seeking causes of negative changes, occurring in CKD patients, scientists tried to draw attention to a heterogenous group of compounds, i.e. advanced glycation end-products (AGEs). The authors determined the level of N ε -(carboxymethyl)lysine (CML), which is one of best known AGEs. Its level was significantly higher in patients with CKD (Group I and Group II) in comparison to subjects with normal renal function. Since there are reports on a negative impact of AGE on peripheral neural cells (20, 21) , it could be concluded that the relationship observed by the authors of this study, reflects to some extent the mentioned impact. Besides, a slight, yet a noticeable difference in CML levels in the studied groups of CKD patients, treated conservatively and chronically haemodialysed, implies a beneficial effect of a renal replacement therapy, contributing to a decrease in the AGE level in the circulation. Further studies incorporating other diagnostic tools such as for instance electrophysiology might help to elucidate and perhaps confirm our observations.
Conclusions
Chronic kidney disease considerably affects the functional state of the visual system. Patients with CKD demonstrate impaired contrast sensitivity and colour vision disturbances. Chronic haemodialysis may improve colour vision.
